ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,150.53
-0.40%
Dow Jones
40,211.72
0.53%
Gold vs US Dollar
2,436.29
0.58%
Brent Oil
83.635
-0.84%
Bitcoin
62,676.86
-3.35%
Pepperstone
Advertisement
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Onyx Pharmaceuticals, Inc. (MM) (ONXX)

  7. Onyx Pharmaceuticals, Inc. (MM) (ONXX) News

Onyx Pharmaceuticals, Inc. (MM) (ONXX)

Onyx Pharmaceuticals, Inc. (MM)
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ONXX
DateTimeSourceHeadlineSymbolCompany
16/02/201021:00PR Newswire (US)Onyx Pharmaceuticals Announces Fourth Quarter and Full Year 2009 Financial Results Teleconference and WebcastNASDAQ:ONXXOnyx Pharmaceuticals, Inc. (MM)
16/02/201018:06Edgar (US Regulatory)Amended Statement of Ownership (SC 13G/A)NASDAQ:ONXXOnyx Pharmaceuticals, Inc. (MM)
12/02/201019:20Edgar (US Regulatory)Amended Statement of Ownership (SC 13G/A)NASDAQ:ONXXOnyx Pharmaceuticals, Inc. (MM)
12/02/201016:01Edgar (US Regulatory)Schedule 13GNASDAQ:ONXXOnyx Pharmaceuticals, Inc. (MM)
12/02/201000:52Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ONXXOnyx Pharmaceuticals, Inc. (MM)
10/02/201001:17Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ONXXOnyx Pharmaceuticals, Inc. (MM)
03/02/201023:50Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ONXXOnyx Pharmaceuticals, Inc. (MM)
03/02/201023:48Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:ONXXOnyx Pharmaceuticals, Inc. (MM)
02/02/201021:00PR Newswire (US)Onyx Pharmaceuticals to Present at the 12th Annual BIO CEO & Investor ConferenceNASDAQ:ONXX
02/02/201013:00PR Newswire (US)Onyx Pharmaceuticals Announces Agreement with the FDA on a Special Protocol Assessment for Planned Phase 3 Carfilzomib CombinatiNASDAQ:ONXX
01/02/201016:15PR Newswire (US)Onyx Pharmaceuticals Appoints Ted W. Love, M.D., as Head of Research & DevelopmentNASDAQ:ONXXOnyx Pharmaceuticals, Inc. (MM)
29/01/201020:00Edgar (US Regulatory)Statement of Ownership (SC 13G)NASDAQ:ONXXOnyx Pharmaceuticals, Inc. (MM)
20/01/201022:26Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ONXXOnyx Pharmaceuticals, Inc. (MM)
20/01/201022:24Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ONXXOnyx Pharmaceuticals, Inc. (MM)
08/01/201000:06Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ONXXOnyx Pharmaceuticals, Inc. (MM)
05/01/201021:00PR Newswire (US)Onyx Pharmaceuticals to Present at the 28th Annual J.P. Morgan Healthcare ConferenceNASDAQ:ONXXOnyx Pharmaceuticals, Inc. (MM)
16/12/200920:16Dow Jones NewsOnyx Pharma Aims To Boost Nexavar Sales, Develop Drug PipelineNASDAQ:ONXXOnyx Pharmaceuticals, Inc. (MM)
11/12/200921:45PR Newswire (US)Nexavar in Combination With Chemotherapy Demonstrates Activity in Patients With Advanced Breast Cancer in Two Phase 2 StudiesNASDAQ:ONXXOnyx Pharmaceuticals, Inc. (MM)
10/12/200921:00PR Newswire (US)Onyx Pharmaceuticals to Webcast Analyst Briefing on Development ProgramNASDAQ:ONXX
07/12/200913:01PR Newswire (US)Carfilzomib Data Demonstrate Promising Efficacy and Tolerability Signals in Ongoing Phase 1b/2 Combination Study with LenalidomiNASDAQ:ONXX
07/12/200913:00PR Newswire (US)Carfilzomib Demonstrates Encouraging Response Rates in Patients with Relapsed and/or Refractory Multiple Myeloma in an Ongoing PNASDAQ:ONXX
06/12/200915:30PR Newswire (US)Carfilzomib Safety Data From Ongoing Phase 2b Pivotal Trial in Relapsed and Refractory Multiple Myeloma Show Promising Safety anNASDAQ:ONXX
04/12/200921:00PR Newswire (US)Onyx Pharmaceuticals to Host American Society of Hematology (ASH) Investor TeleconferenceNASDAQ:ONXXOnyx Pharmaceuticals, Inc. (MM)
04/12/200917:33Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ONXXOnyx Pharmaceuticals, Inc. (MM)
02/12/200912:00PR Newswire (US)S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of MyeloprolifeNASDAQ:ONXX
25/11/200921:00PR Newswire (US)Onyx Pharmaceuticals Announces December 2009 Investor EventsNASDAQ:ONXX
19/11/200913:22Dow Jones NewsUPDATE: UK Watchdog Says Bayer Liver Drug Nexavar Too ExpensiveNASDAQ:ONXXOnyx Pharmaceuticals, Inc. (MM)
19/11/200911:39Dow Jones NewsUK Watchdog Says Bayer Liver Drug Nexavar Too ExpensiveNASDAQ:ONXXOnyx Pharmaceuticals, Inc. (MM)
18/11/200902:27Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ONXXOnyx Pharmaceuticals, Inc. (MM)
18/11/200902:26Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:ONXXOnyx Pharmaceuticals, Inc. (MM)
 Showing the most relevant articles for your search:NASDAQ:ONXX

Your Recent History

BOV
TAEE4
TAESA PN
NYSE
NMD
LSE
BN11
Citi Fun 26
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved